Second pregnancy outcomes for women with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 72, Issue 4, 2013, Pages 547-551

  Shand, Antonia W ^a,b   Algert, Charles S ^a   March, Lyn ^c   Roberts, Christine L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; AUSTRALIA; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; OUTCOME ASSESSMENT; PERINATAL DEATH; PERINATAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM;

ABORTION, SPONTANEOUS; ADULT; COHORT STUDIES; FEMALE; FETAL DEATH; FOLLOW-UP STUDIES; GRAVIDITY; HUMANS; LIVE BIRTH; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEW SOUTH WALES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; STILLBIRTH; THROMBOEMBOLISM;

EID: 84874403699     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-201210     Document Type: Article

References (25)

1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308-18. (Pubitemid 43828810)
2. Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010;5:2060-8.
3. Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:514-21. (Pubitemid 40216315)
4. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:899-907.
5. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005;32:1709-12. (Pubitemid 41324808)
6. Centre for Health Record Linkage. CHeReL Quality Assurance Procedures for Record Linkage: http://www.cherel.org.au/downloads.html (accessed March 2011).
7. Chibnik LB, Massarotti EM, Costenbader KH. Identification and validation of lupus nephritis cases using administrative data. Lupus 2010;19:741-3.
8. Hadfield RM, Lain SJ, Cameron CA, et al. The prevalence of maternal medical conditions during pregnancy and a validation of their reporting in hospital discharge data. Aust N Z J Obstet Gynaecol 2008;48:78-82. (Pubitemid 351239145)
9. Taylor LK, Travis S, Pym M, et al. How useful are hospital morbidity data for monitoring conditions occurring in the perinatal period? Aust N Z J Obstet Gynaecol 2005;45:36-41. (Pubitemid 40424713)
10. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care 2006;44:1011-9. (Pubitemid 44674033)
11. Roberts CL, Lancaster PA. Australian national birthweight percentiles by gestational age. Med J Aust 1999;170:114-8. (Pubitemid 29060342)
12. Lain SJ, Roberts CL, Hadfield RM, et al. How accurate is the reporting of obstetric haemorrhage in hospital discharge data? A validation study. Aust N Z J Obstet Gynaecol 2008;48:481-4.
13. Roberts CL, Bell JC, Ford JB, et al. The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens Pregnancy 2008;27:285-97.
14. Roberts CL, Bell JC, Ford JB, et al. Monitoring the quality of maternity care: how well are labour and delivery events reported in population health data? Paediatr Perinat Epidemiol 2009;23:144-52.
15. Taylor LK, Pym M, Bajuk B, et al. Validation study: NSW midwives data collection 1998. NSW Mothers and Babies 1998 2000;9(S-2):97-9.
16. Clowse ME, Magder LS, Witter F, et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006;107:293-9.
17. Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:127.e1-6.
18. Hutter D, Silverman ED, Jaeggi ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol 2010;72:235-41.
19. Mevorach D, Elchalal U, Rein AJ. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Curr Opin Rheumatol 2009;21:478-82.
20. Ekblom-Kullberg S, Kautiainen H, Alha P, et al. Reproductive health in women with systemic lupus erythematosus compared to population controls. Scand J Rheumatol 2009;38:375-80.
21. Vinet E, Labrecque J, Pineau CA, et al. A population-based assessment of live births in women with systemic lupus erythematosus. Ann Rheum Dis 2012;71:557-9.
22. Ford JB, Roberts CL, Bell JC, et al. Postpartum haemorrhage occurrence and recurrence: a population-based study. Med J Aust 2007;187:391-3.
23. Dhar JP, Essenmacher LM, Ager JW, et al. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 2005;193:1444-55. (Pubitemid 41395116)
24. Buyon JP, Garabet L, Kim M, et al. Favorable prognosis in a large, prospective multicenter study of lupus pregnancies (abstract). Arthritis Rheum 2011;63:1707.
25. Kwok LW, Tam LS, Zhu T, et al. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 2011;20:829-36.